BLT 0.00% 2.6¢ benitec biopharma limited

Ann: Appendix 4C - quarterly, page-41

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    Don't forget our competitors in the rnai field, Dicerna, Regulus, Artubus, Alnylam, are years ahead of us, having been through clinical trials, but with mixed results.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.